4,4'-Bis(trans-4-propylcyclohexyl)-1,1'-biphenyl

Catalog No. :
ACXAIJ143
CAS No. :
85600-56-2
Molecular Formula :
C30H42
Molecular Weight :
402.67

IUPAC Name:4,4'-bis((1s,4r)-4-propylcyclohexyl)-1,1'-biphenyl

4,4'-Bis(trans-4-propylcyclohexyl)-1,1'-biphenyl structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$64.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,4'-Bis(trans-4-propylcyclohexyl)-1,1'-biphenyl
IUPAC Name4,4'-bis((1s,4r)-4-propylcyclohexyl)-1,1'-biphenyl
MDL No.MFCD11053445
Molecular FormulaC30H42
Molecular Weight402.67
SMILESCCC[C@H]1CC[C@H](C2=CC=C(C3=CC=C([C@H]4CC[C@H](CCC)CC4)C=C3)C=C2)CC1
InChI KeyLUCHFKBTWHPREI-KKLUKGEUSA-N
Synonym4-n-propyl cyclohexyl-4'-n-propyl cyclohexyl biphenyl | 1-(4-propylcyclohexyl)-4-[4-(4-propylcyclohexyl)phenyl]benzene | 1,1'-Biphenyl, 4,4'-bis(4-propylcyclohexyl)- | 4,4'-Bis(4-propylcyclohexyl)-1,1'-biphenyl | A914627 | CS-0152577 | MFCD11053445 | 4,4
CAS No.85600-56-2
PubChem CID634081

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACXAIJ143 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKLQU157 route compound structure diagram
    ACKLQU15786579-53-5 In Stock
  2. Plus
  3. ACKLQU157 route compound structure diagram
    ACKLQU15786579-53-5 In Stock
  4. Then
  5. ACXAIJ143 route product structure diagram
    ACXAIJ14385600-56-2 In Stock
Inquiry

2. ACXAIJ143 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFOMU317 route compound structure diagram
    ACFOMU317146862-02-4 In Stock
  2. Plus
  3. ACKLQU157 route compound structure diagram
    ACKLQU15786579-53-5 In Stock
  4. Then
  5. ACXAIJ143 route product structure diagram
    ACXAIJ14385600-56-2 In Stock
Inquiry

Comments (0)